AKT1 and Insulin resistance: Targeting the AMPK signaling pathway to promote glucose utilization via CTRP may offer a therapeutic target to restore glucose homeostasis by acting on glucose uptake independently of the PI3K/PKB/Akt pathway and, thus, reduce insulin resistance.